D-1309-2019 Class I Terminated

Recalled by Novartis Pharmaceuticals Corp. — East Hanover, NJ

Recall Details

Product Type
Drugs
Report Date
May 29, 2019
Initiation Date
May 11, 2019
Termination Date
November 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
792 cartons

Product Description

Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.

Reason for Recall

Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.

Distribution Pattern

Nationwide with in the United States

Code Information

Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020.